Connect with Sinopep-Allsino Biopharmaceutical Co., Ltd. at Hi Korea 2024
Exhibiting at Hi Korea 2..Hi Korea 2024
Hall ..Hall A, COEX, Seoul, Korea
27 Aug - 29 Aug, 2024
N33N33
Sinopep-Al...
Add to Leads
Company Type
Manufacturing
Product Categories
Pharmaceutical Ingredients
Biopharmaceuticals
Product Items
Peptides
Oligonucleotides
Small Molecules
APIs
Intermediates
Company Overview
Sinopep-Allsino Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company based in China, focusing on the research, development, and production of peptide drugs, small molecule drugs, and oligonucleotide drugs. Established in 2009, the company operates multiple R&D and manufacturing sites, including facilities in Hangzhou and Lianyungang. Sinopep-Allsino is known for its advanced technology and high-quality CRDMO (Contract Research, Development, and Manufacturing Organization) services, providing end-to-end solutions from laboratory research to commercial production. The company has passed multiple FDA inspections and holds significant expertise in developing APIs for highly demanded peptide products such as Semaglutide, Tirzepatide, and Liraglutide.
Videos & Images
Exhibitor Contact
Address
No. 28 Linpu Road, Dapu Industrial Zone, Lianyungang Economic and Technological Development Zone, Jiangsu, 222000, China
Sinopep-Allsino Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company based in China, focusing on the research, development, and production of peptide drugs, small molecule drugs, and oligonucleotide drugs. Established in 2009, the company operates multiple R&D and manufacturing sites, including facilities in Hangzhou and Lianyungang. Sinopep-Allsino is known for its advanced technology and high-quality CRDMO (Contract Research, Development, and Manufacturing Organization) services, providing end-to-end solutions from laboratory research to commercial production. The company has passed multiple FDA inspections and holds significant expertise in developing APIs for highly demanded peptide products such as Semaglutide, Tirzepatide, and Liraglutide.
